Produkty 4728-30-7

CAS 4728-30-7 występuje w naszej ofercie pod nazwami: Isopimara-8(14),15-dien-3β-ol, ent-Isopimara-8(14),15-diene-3β-ol, ≥95%, ≥95%, Sandaracopimaradien-3β-ol. Oferty producentów: Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 5mg, 1mg, 10mg, 25mg, 50mg, Get quote.

Isopimara-8(14),15-dien-3β-ol
Biosynth
  • opakowanie: 5mg, 1mg, 10mg, 25mg
  • Warianty: 5
Zobacz produkt
ent-Isopimara-8(14),15-diene-3β-ol, ≥95%, ≥95%
Chemat
  • opakowanie: 5mg
  • Warianty: 1
od 5234,00
Zobacz produkt
Sandaracopimaradien-3β-ol
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2S,4aR,4bS,7R,10aR)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,4b,5,6,9,10,10a-octahydro-2H-phenanthren-2-ol (CAS 4728-30-7) to związek chemiczny o wzorze sumarycznym C20H32O i masie molowej 288.5 g/mol. Nazwa systematyczna IUPAC: (2S,4aR,4bS,7R,10aR)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,4b,5,6,9,10,10a-octahydro-2H-phenanthren-2-ol. InChIKey: ATQOOBSXQVRQPY-VDWQKOAOSA-N.

Dane identyfikacyjne
Wzór sumarycznyC20H32O
Masa molowa288.5 g/mol
Nazwa IUPAC(2S,4aR,4bS,7R,10aR)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,4b,5,6,9,10,10a-octahydro-2H-phenanthren-2-ol
InChIKeyATQOOBSXQVRQPY-VDWQKOAOSA-N
SMILESC[C@@]1(CC[C@H]2C(=C1)CC[C@@H]3[C@@]2(CC[C@@H](C3(C)C)O)C)C=C

Dane obliczone przez PubChem (NCBI)

Synonimy: 8(14),15-Isopimaradien-3-ol, Isopimara-8(14),15-dien-3beta-ol, Sandaracopimaradien-3|A-ol, ent-Isopimara-8(14),15-diene-3beta-ol, ent-Isopimara-8(14),15-diene-3|A-ol, Sandaracopimaradien-3-ol, Sandaracopimaradien-3|?-ol, orb1683306, (3beta,13alpha)-Pimara-8(14),15-dien-3-ol
Izomery (ten sam wzór sumaryczny)
1-phenyltetradecan-1-one C20H32O
(4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-4,6,8-trien-1-ol C20H32O
[(1S,4S,5R,9S,10R,13R)-5,9-dimethyl-14-methylidene-5-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]methanol C20H32O
(8R,9S,10R,13S,14S,17S)-17-ethyl-13-methyl-2,3,4,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol C20H32O
(5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol C20H32O
(8R,9S,10R,13S,14S,17S)-17-ethyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol C20H32O
(5S,8R,9S,10S,13S,14S,17S)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol C20H32O
(3R,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-4,6,8-trien-1-ol C20H32O
[(1S,4aR,5S,8aR)-1,4a-dimethyl-6-methylidene-5-[(2E)-3-methylpenta-2,4-dienyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methanol C20H32O
(8R,9S,10S,13S,14S,17S)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol C20H32O
(2R,4bS,7S,8aS,10aS)-7-ethenyl-1,1,4b,7-tetramethyl-3,5,6,8,8a,9,10,10a-octahydro-2H-phenanthren-2-ol C20H32O